Neuland Laboratories Limited (BOM: 524558)

Market Cap	199.47B
Revenue (ttm)	15.28B
Net Income (ttm)	2.80B
Shares Out	12.83M
EPS (ttm)	217.98
PE Ratio	71.33
Forward PE	59.61
Dividend	14.00 (0.09%)
Ex-Dividend Date	Jul 12, 2024

Volume	1,613
Open	13,909
Previous Close	13,787
Day's Range	13,909 - 16,545
52-Week Range	4,928 - 16,545
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Neuland Laboratories

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1984
• Employees: 1,643
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524558

Financial Performance

In 2023, Neuland Laboratories's revenue was 15.59 billion, an increase of 30.81% compared to the previous year's 11.91 billion. Earnings were 3.00 billion, an increase of 83.51%.